{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:13:19Z","timestamp":1791411199827,"version":"4.3.3"},"reference-count":67,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.schres.2013.02.023","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T17:39:07Z","timestamp":1363369147000},"page":"162-169","source":"Crossref","is-referenced-by-count":27,"title":["Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: An animal model"],"prefix":"10.1016","volume":"146","author":[{"given":"Melanie Dawn","family":"Guenette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adria","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araba","family":"Chintoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Arenovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2013.02.023_bb0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1748-1716.1982.tb07073.x","article-title":"Enhancement of insulin secretion during selective blockade of alpha 1- and alpha 2-adrenoceptors in the rat: effects of somatostatin","volume":"115","author":"Ahren","year":"1982","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.schres.2013.02.023_bb0010","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2008.06.105","article-title":"The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063","volume":"592","author":"Assie","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/0026-0495(93)90129-C","article-title":"Involvement of insulinemia in the postprandial hypotriacylglycerolemia induced by prazosin in the rat","volume":"42","author":"Belahsen","year":"1993","journal-title":"Metabolism"},{"issue":"Suppl. 3","key":"10.1016\/j.schres.2013.02.023_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1365-2362.32.s3.5.x","article-title":"The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes","volume":"32","author":"Bergman","year":"2002","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.schres.2013.02.023_bb0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.pnpbp.2010.04.024","article-title":"A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model","volume":"34","author":"Boyda","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2013.02.023_bb0030","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.neuropharm.2011.02.019","article-title":"Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats","volume":"62","author":"Boyda","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2013.02.023_bb0035","series-title":"Compendium of Pharmaceuticals and Specialties (CPS)","author":"Canadian Pharmacists Association","year":"2012"},{"key":"10.1016\/j.schres.2013.02.023_bb0040","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0022-3565(25)39283-9","article-title":"5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat","volume":"243","author":"Chaouloff","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.schres.2013.02.023_bb0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00180665","article-title":"Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat","volume":"341","author":"Chaouloff","year":"1990","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0014-2999(90)90370-L","article-title":"Effects of the 5-HT1C\/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat","volume":"187","author":"Chaouloff","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0055","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00213-006-0490-4","article-title":"WAY-100635 is a potent dopamine D4 receptor agonist","volume":"188","author":"Chemel","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2013.02.023_bb0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0165-1838(00)00106-5","article-title":"Activation of adenosine A1 receptors by drugs to lower plasma glucose in streptozotocin-induced diabetic rats","volume":"83","author":"Cheng","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.schres.2013.02.023_bb0065","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1566-0702(00)00197-1","article-title":"Role of alpha1A-adrenoceptor in the regulation of glucose uptake into white adipocyte of rats in vitro","volume":"84","author":"Cheng","year":"2000","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.schres.2013.02.023_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JCP.0b013e318184b4c5","article-title":"Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration","volume":"28","author":"Chintoh","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2008.06.006","article-title":"Insulin resistance following continuous, chronic olanzapine treatment: an animal model","volume":"104","author":"Chintoh","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2013.02.023_bb0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.schres.2008.12.012","article-title":"Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model","volume":"108","author":"Chintoh","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2013.02.023_bb0085","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.schres.2013.02.023_bb0090","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2337\/diacare.19.3.278","article-title":"In praise of the hyperglycemic clamp. A method for assessment of beta-cell sensitivity and insulin resistance","volume":"19","author":"Elahi","year":"1996","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.schres.2013.02.023_bb0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00005344-199609000-00009","article-title":"Glucose tolerance and postprandial glucose and insulin kinetics in rats with short- and long-term alpha 1-adrenergic blockade","volume":"28","author":"Fajardo","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-007-0891-z","article-title":"Opposing effects of 5-HT(2A) and 5-HT(2C) receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test","volume":"195","author":"Fletcher","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2013.02.023_bb0105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/0897190006294180","article-title":"Complete resolution of olanzapine-induced diabetic ketoacidosis","volume":"19","author":"Fulbright","year":"2006","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.schres.2013.02.023_bb0110","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/diacare.22.6.1002","article-title":"Diabetic ketoacidosis with olanzapine treatment","volume":"22","author":"Gatta","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.schres.2013.02.023_bb0115","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.psy.0000174994.91245.34","article-title":"Antagonism of the serotonin 5-HT-2 receptor and insulin sensitivity: implications for atypical antipsychotics","volume":"67","author":"Gilles","year":"2005","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.schres.2013.02.023_bb0120","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0014-2999(91)90598-K","article-title":"An alpha 1-adrenoceptor-sensitive mechanism is responsible for the adrenergic inhibition of insulin secretion in the pig pancreas","volume":"200","author":"Gregersen","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0125","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1677\/joe.0.0780239","article-title":"Association between 5-hydroxytryptamine release and insulin secretion","volume":"78","author":"Gylfe","year":"1978","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.schres.2013.02.023_bb0130","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2011.06.004","article-title":"Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: an animal model","volume":"131","author":"Hahn","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2013.02.023_bb0135","doi-asserted-by":"crossref","first-page":"13563","DOI":"10.1074\/jbc.274.19.13563","article-title":"Serotonin (5-Hydroxytryptamine), a novel regulator of glucose transport in rat skeletal muscle","volume":"274","author":"Hajduch","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.schres.2013.02.023_bb0140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainres.2004.03.032","article-title":"Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats","volume":"1011","author":"Hayashi","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2013.02.023_bb0145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/sj.npp.1301209","article-title":"Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects","volume":"32","author":"Houseknecht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2013.02.023_bb0150","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/sj.bjp.0701312","article-title":"Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat","volume":"121","author":"Jackson","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0155","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s002130050729","article-title":"The effects of 5-HT1A receptor agonists, 5-HT1A receptor antagonists and their interaction on the fear-potentiated startle response","volume":"139","author":"Joordens","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2013.02.023_bb0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0165","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.npp.1300027","article-title":"H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs","volume":"28","author":"Kroeze","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2013.02.023_bb0170","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0024-3205(81)90747-5","article-title":"Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors","volume":"28","author":"Leysen","year":"1981","journal-title":"Life Sci."},{"key":"10.1016\/j.schres.2013.02.023_bb0175","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/pdi.948","article-title":"A combination of atypical antipsychotics and diabetic ketoacidosis","volume":"23","author":"Macfarlane","year":"2006","journal-title":"Pract. Diab. Int."},{"key":"10.1016\/j.schres.2013.02.023_bb0180","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1592\/phco.28.9.1198","article-title":"Diabetic ketoacidosis associated with aripiprazole","volume":"28","author":"Makhzoumi","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.schres.2013.02.023_bb0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(88)90698-X","article-title":"5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge","volume":"151","author":"McCall","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2013.02.023_bb0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0924-977X(03)00072-5","article-title":"Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro","volume":"14","author":"Melkersson","year":"2004","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0200","first-page":"390","article-title":"The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs","volume":"25","author":"Meltzer","year":"1989","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.schres.2013.02.023_bb0205","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.psyneuen.2007.05.007","article-title":"Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats","volume":"32","author":"Murashita","year":"2007","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2013.02.023_bb0210","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2013.02.023_bb0215","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/2647","article-title":"Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene","volume":"4","author":"Nonogaki","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.schres.2013.02.023_bb0220","doi-asserted-by":"crossref","first-page":"e1000229","DOI":"10.1371\/journal.pbio.1000229","article-title":"Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation","volume":"7","author":"Paulmann","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.schres.2013.02.023_bb0225","unstructured":"Physicians' Desk Reference, 2012. 66th ed. Thomson PDR, Montvale, NJ."},{"key":"10.1016\/j.schres.2013.02.023_bb0230","doi-asserted-by":"crossref","first-page":"655","DOI":"10.7326\/0003-4819-119-7_Part_2-199310011-00006","article-title":"Medical hazards of obesity","volume":"119","author":"Pi-Sunyer","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.schres.2013.02.023_bb0235","first-page":"34","article-title":"Pancreatitis and diabetic ketoacidosis with quetiapine use","volume":"6","author":"Rashid","year":"2009","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.schres.2013.02.023_bb0240","doi-asserted-by":"crossref","first-page":"564","DOI":"10.2337\/diabetes.48.3.564","article-title":"Acute vasoconstriction-induced insulin resistance in rat muscle in vivo","volume":"48","author":"Rattigan","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.schres.2013.02.023_bb0245","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s004240050132","article-title":"Calcium- and barium-dependent exocytosis from the rat insulinoma cell line RINm5F assayed using membrane capacitance measurements and serotonin release","volume":"432","author":"Richmond","year":"1996","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.schres.2013.02.023_bb0250","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1176827","article-title":"Overexpression of alpha2A-adrenergic receptors contributes to type 2 diabetes","volume":"327","author":"Rosengren","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.schres.2013.02.023_bb0255","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1074\/jbc.M505560200","article-title":"Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion","volume":"280","author":"Rubi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.schres.2013.02.023_bb0260","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1385\/ENDO:8:3:213","article-title":"Neurotransmitters and their receptors in the islets of Langerhans of the pancreas: what messages do acetylcholine, glutamate, and GABA transmit?","volume":"8","author":"Satin","year":"1998","journal-title":"Endocrine"},{"key":"10.1016\/j.schres.2013.02.023_bb0265","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejphar.2007.09.015","article-title":"Reduced blood glucose levels, increased insulin levels and improved glucose tolerance in alpha2A-adrenoceptor knockout mice","volume":"578","author":"Savontaus","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2013.02.023_bb0270","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1469-7793.1999.00651.x","article-title":"Quantal analysis of 5-hydroxytryptamine release from mouse pancreatic beta-cells","volume":"521","author":"Smith","year":"1999","journal-title":"J. Physiol."},{"key":"10.1016\/j.schres.2013.02.023_bb0275","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00125-008-1152-3","article-title":"Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat","volume":"51","author":"Smith","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/j.schres.2013.02.023_bb0280","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0893-133X(99)00057-3","article-title":"Comparison of the novel antipsychotic ziprasidone with clozapine and olanzapine: inhibition of dorsal raphe cell firing and the role of 5-HT1A receptor activation","volume":"21","author":"Sprouse","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2013.02.023_bb0285","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eurpsy.2009.01.001","article-title":"How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins","volume":"24","author":"Starrenburg","year":"2009","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2013.02.023_bb0290","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/374542a0","article-title":"Eating disorder and epilepsy in mice lacking 5-HT2c serotonin receptors","volume":"374","author":"Tecott","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.schres.2013.02.023_bb0295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000126970","article-title":"Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat","volume":"63","author":"Uvnas-Moberg","year":"1996","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.schres.2013.02.023_bb0300","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bbrc.2006.10.033","article-title":"Deletion of the serotonin 2c receptor from transgenic mice overexpressing leptin does not affect their lipodystrophy but exacerbates their diet-induced obesity","volume":"351","author":"Wang","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.schres.2013.02.023_bb0305","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00002018-200124010-00005","article-title":"Bodyweight gain with atypical antipsychotics. A comparative review","volume":"24","author":"Wetterling","year":"2001","journal-title":"Drug Saf."},{"key":"10.1016\/j.schres.2013.02.023_bb0310","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0006-3223(98)00100-0","article-title":"Novel antipsychotics and new onset diabetes","volume":"44","author":"Wirshing","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2013.02.023_bb0315","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4088\/JCP.v60n0602","article-title":"Novel antipsychotics: comparison of weight gain liabilities","volume":"60","author":"Wirshing","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.02.023_bb0320","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.neuron.2008.09.033","article-title":"5-HT2CRs expressed by pro-opiomelanocortin neurons regulate energy homeostasis","volume":"60","author":"Xu","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.schres.2013.02.023_bb0325","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cmet.2007.10.008","article-title":"Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways","volume":"6","author":"Zhou","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.schres.2013.02.023_bb0330","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","article-title":"Thiazide diuretics, potassium, and the development of diabetes: a quantitative review","volume":"48","author":"Zillich","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.schres.2013.02.023_bb0335","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1192\/bjp.187.6.537","article-title":"Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol","volume":"187","author":"Zipursky","year":"2005","journal-title":"Br. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:41:11Z","timestamp":1745973671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996413001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":67,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0920996413001151"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2013.02.023","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}